Cervical cancer vaccines may cut need for screening
Nov 09 2011
(Reuters) - Using GlaxoSmithKline's Cervarix vaccine to protect girls against the HPV virus that causes cervical cancer is so effective that health authorities could reduce the need for later cervical screening, scientists said on Wednesday. To read more click here.
